Found: 8
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 619, doi. 10.1111/1440-1681.13662
- Publication type:
- Article
The L‐arginine‐NO‐cGMP pathway mediates the locomotor activity alterations during the expression of sensitization to mephedrone in mice.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 621, doi. 10.1111/1440-1681.13779
- By:
- Publication type:
- Article
Protective effect of melatonin and ascorbic acid combination on sepsis‐induced lung injury: An Experimental study.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 634, doi. 10.1111/1440-1681.13780
- By:
- Publication type:
- Article
Mechanism of ligusticum cycloprolactam against neuroinflammation based on network pharmacology and experimental verification.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 647, doi. 10.1111/1440-1681.13784
- By:
- Publication type:
- Article
Rosavin protects the blood–brain barrier against ischemia/reperfusion‐induced cerebral injury by regulating MAPK‐mediated MMPs pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 664, doi. 10.1111/1440-1681.13781
- By:
- Publication type:
- Article
Combination of SVI/S′ and diagnostic scores for heart failure with preserved ejection fraction.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 677, doi. 10.1111/1440-1681.13782
- By:
- Publication type:
- Article
Bufalin reduces myocardial infarction‐induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL‐1β signalling pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 688, doi. 10.1111/1440-1681.13783
- By:
- Publication type:
- Article
Geldanamycin ameliorates multiple organ dysfunction and microthrombosis in septic mice by inhibiting the formation of the neutrophil extracellular network by activating heat shock factor 1 HSF1.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 8, p. 698, doi. 10.1111/1440-1681.13798
- By:
- Publication type:
- Article